Precision medicine solutions
for healthcare institutions, pharmaceutical companies and academic researchers
A unique lab solutions dedicated portal with high-value scientific materials and major updates in the field of oncology, genetics and precision medicine.
Case of the Month
July: 53 years-old man with Non-Small Cell Lung Cancer
2 min reading
Published Jul 24th
Case description: A 53 year-old man was diagnosed with a metastatic Non-Small Cell Lung Cancer (mNSCLC) in 2021. This patient was a non-smoker. In 2022, a biopsy from a bone metastasis was tested using our OncoDEEP. The analysis revealed an EGFR exon 19 deletion (p.E746_A750del) which is an activating mutation. In addition, we detected an […]
Dive Deep into OncoDNA’s journey tells by its founder Jean-Pol Detiffe ! In this video interview, you’ll discover the inspiration behind OncoDNA’s tests and its pioneering decentralized solution: OncoDEEP Kit. But that’s not all! Jean-Pol...
Cancer Management: Breast Cancer
What is Breast Cancer? With an estimated 2.26 million new cancer cases and 685 000 deaths in women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in 2020,...
Testimonial – “A True Story About Data”
Once upon a time, in a world where personalized medicine was a luxury reserved for the few, a small but passionate group embarked on an audacious journey to change precision medicine. It was a crazy...
Streamlining Operations to get the Most from Lab Resources
Biomarker testing is critical to learning more about each patient’s tumor type and can be used to help determine treatment options. Based on the test results, patients may be matched with targeted therapies aimed at...
June: 60 years old Woman with Metastatic Ovarian Cancer
Case description: A 60-year-old woman was diagnosed with high-grade serious ovarian cancer in 2021. She went under surgery followed by platinum-containing adjuvant chemotherapy. After nearly 2 years, she progressed and her CT scan revealed liver...
Cancer Management: Ovarian Cancer
What is Ovarian Cancer? With an estimated 313 959 new cancer cases and 207 252 deaths in women, ovarian cancer is the 7th most commonly diagnosed cancer and the 8th cause of cancer death in...
Ensuring a Robust DNA Analysis and the Best Clinical Interpretation by Generating a High-Quality Data Set
OncoDEEP® Kit enables laboratories to achieve and consistently replicate high-quality sequencing data regarding coverage and sensitivity. Based on analytical performance this Whitepaper assesses the precision of OncoDEEP® Kit while measuring the repeatability and reproducibility. Combined...
Cancer Management: Lung Cancer
What is Lung Cancer ? With an estimated 2.2 million new cancer cases and 1.8 million deaths, lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death in 2020,...
White Paper: Homologous Recombination Deficiency (HRD) Assessment for Clinical Management using the OncoDEEP® Kit
The Homologous Recombination Repair (HRR) pathway repairs DNA double-strand breaks (DSB). HRR deficiency leads to the accumulation of genomic aberrations and genomic instability which can promote malignant transformation. This phenotype of loss of the HRR...
OncoKDM’s comprehensive interpretation reports provide labs with eight essential assets to enhance the understanding of NGS data, including detailed annotations, a list of actionable variants, a list of therapies recommendations, and a summary of relevant...
They trust us, we trust them
Years of trust, countless tests run, genes, and trials explored.
Our mission
OncoDNA’s ultimate mission is to improve all patients’ health by empowering healthcare providers, biopharma companies and researchers to deliver the promise of precision medicine. In this relentless pursuit of better care, we have been building an ecosystem of partners involved along the entire value chain – from translational research and drug development to patient treatment, monitoring and reimbursement.
